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Background: 5-methylcytosine (mC) can be oxidized by the tet methylcytosine dioxygenase (Tet) family of
enzymes to 5-hydroxymethylcytosine (hmC), which is an intermediate of mC demethylation and may also be a
stable epigenetic modification that influences chromatin structure. hmC is particularly abundant in mammalian
brains but its function is currently unknown. A high-resolution hydroxymethylome map is required to fully
understand the function of hmC in the human brain.
Results: We present genome-wide and single-base resolution maps of hmC and mC in the human brain by combined
application of Tet-assisted bisulfite sequencing and bisulfite sequencing. We demonstrate that hmCs increase markedly
from the fetal to the adult stage, and in the adult brain, 13% of all CpGs are highly hydroxymethylated with strong
enrichment at genic regions and distal regulatory elements. Notably, hmC peaks are identified at the 5′splicing sites at
the exon-intron boundary, suggesting a mechanistic link between hmC and splicing. We report a surprising transcription-
correlated hmC bias toward the sense strand and an mC bias toward the antisense strand of gene bodies. Furthermore,
hmC is negatively correlated with H3K27me3-marked and H3K9me3-marked repressive genomic regions, and is more
enriched at poised enhancers than active enhancers.
Conclusions: We provide single-base resolution hmC and mC maps in the human brain and our data imply novel roles
of hmC in regulating splicing and gene expression. Hydroxymethylation is the main modification status for a large portion
of CpGs situated at poised enhancers and actively transcribed regions, suggesting its roles in epigenetic tuning at
these regions.Background
Methylation of cytosine (mC) plays a role in many crucial
cellular processes. In 2009, it was shown that mC can be
oxidized to 5-hydroxymethylcytosine (hmC) by tet methyl-
cytosine dioxygenase (Tet) family of enzyme, and that em-
bryonic stem cells (ESCs) and mouse brain tissues contain
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reproduction in any medium, provided the orevidently suggested that hmC is an intermediate in the
long pursued pathway of active DNA demethylation [3,4].
Soon after the discovery, a series of genome-wide map-
ping studies of hmC were performed using affinity or
enzyme-based approaches by us and others [5-16]. These
studies, at low resolution and semi-quantitative, have pro-
vided significant insights into the distribution and func-
tions of hmC at distal regulatory elements, gene bodies,
and polycomb repression complex-bound promoters.
More recently, two bisulfite-sequencing (BS-Seq) derived
methods, Tet-assisted bisulfite sequencing (TAB-Seq) and
oxidative bisulfite sequencing (oxBS-Seq), were established
to quantitatively sequence hmC at base resolution [17,18].
The first genome-wide application of TAB-Seq to mam-
malian ESCs revealed novel characters of hmC such as itsd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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binding sites [17].
The content of hmC in the mammalian brain is typic-
ally five to ten times higher than in any other tissues,
suggesting a potential role for hmC in the brain [2,8,19].
hmC could be an intermediate of mC demethylation,
suggesting a potential high turnover rate of DNA methy-
lation in the brain [20]. In addition, given its high abun-
dance and stability, hmC could act as an epigenetic
modification that influences genome structure and func-
tion by recruiting chromatin modifiers [21,22]. Recent
studies have shown that Tet1 mutant mice exhibit mem-
ory defects, suggesting that DNA hydroxymethylation
plays an important role in normal brain function [23,24].
However, the exact function of hmC in the mammalian
brain remains to be understood. Recently, Lister et al. re-
ported comprehensive genome-wide DNA methylation
maps in the human and mouse brain using BS-Seq, which
also include hmC maps in the mouse brain using TAB-
Seq [25]. Here, we applied TAB-Seq combined with BS-
Seq to map the DNA hydroxymethylome and methylome
at single-base resolution in the human brain. Our data un-
covered new features of hmC including hmC peaks at 5′
splicing sites and a transcription-corrected hmC bias to-
ward the sense strand of gene bodies, implying novel roles
of hmC in regulating splicing and gene expression in the
brain.
Results and discussion
Base-resolution hydroxymethylome and methylome
mapping in the human brain and identification of
highly hydroxymethylated cytosines
We performed TAB-Seq and BS-Seq on a DNA sample
isolated from the prefrontal cortex of an adult individual
and sequenced it to an average depth of 22× per strand by
TAB-Seq and 9.3× by BS-Seq. For TAB-Seq, we observed
a low non-conversion rate of unmodified cytosine (0.36%)
and mC (1.18%), and a high protection rate of hmC
(97.6%). We also applied TAB-Seq to a DNA sample iso-
lated from the prefrontal cortex of a fetal brain and se-
quenced it to an average depth of 11× per strand, with the
non-conversion rates of unmodified cytosine and mC be-
ing 0.25% and 1.51%, respectively. The sequencing details
are summarized in Additional file 1. TAB-Seq detected ap-
proximately 28.4 million hmCs in the adult prefrontal cor-
tex, 10-fold more than that in the fetal prefrontal cortex
(approximately 2.6 million), and BS-Seq detected approxi-
mately 49.9 million modified cytosines (modCs) (false dis-
covery rate ≤1%; Figure 1A, and see Materials and
methods). The much higher number of hmCs detected in
the adult prefrontal cortex is consistent with previous re-
ports [8,9]. To quantitatively verify this, we performed li-
quid chromatography-tandem mass spectrometry (LC-
MS/MS) to genomic DNAs isolated from several regionsof these two brain samples, as well as another pair of fetal
and adult brain samples, and the results confirmed that
the abundance of hmC in the adult human brain is nearly
six times higher than that in the fetal brain (%hmC/dC
average 0.866 vs 0.154) (Additional files 2 and 3). Whereas
a notable portion of modC exists in non-CpG contexts in
the adult prefrontal cortex (16.1% in CHH and 2.8% in
CHG, where H =A, C or T), hmC exists predominantly in
CpG context (97.4% in the adult cortex and 99.86% in the
fetal cortex), which is in line with the finding in mouse
[25] (Figure 1a). We also applied BS-Seq and TAB-Seq to
a DNA sample extracted from the hippocampus of the
fetal brain, and found that both modC and hmC exists
predominantly in CpG context, confirming the previous
finding that the non-CpG modification in the brain is
adult-specific [25] (Additional file 4). Since the majority of
hmC exists in a CpG context, we next focused our analysis
on CpG modifications.
Examples of the hmC and mC maps were shown in
Figure 1b. A genomic region of 12 mb (mega base pairs)
on chromosome 4 displays increased hmC levels in gene-
rich regions, coincident with a decrease in mC levels;
these changes could not be distinguished by traditional bi-
sulfite sequencing alone because the modC levels mea-
sured by BS-Seq change only slightly. Closer inspection of
a 12 kb (kilo base pairs) region around the TET2 tran-
scription start site (TSS) further supports the need for
TAB-Seq. For many individual CpG sites, the hmC level is
higher than the mC level. In particular, the highly modified
CpGs immediately upstream the TSS are highly hydroxy-
methylated and could be mistaken as highly methylated
sites when applying traditional BS-Seq alone. These results
highlight the need to apply TAB-Seq to distinguish hmC
and mC unequivocally for obtaining accurate hydroxy-
methylation and methylation maps in the brain. The hmC
map of the fetal brain is also provided and suggested that
patterns of hmCs in the adult brain have been partially
established in the fetal stage.
We calculated the modification frequency of hmC and
mC for individual CpG sites. In general, hmCs occur at
relatively low frequency (median 29.2% and 30.8% in the
adult and fetal brains, respectively), whereas most mCs
occur at high frequency (median 59.7% in the adult brain)
(Additional file 5a and b). Then we classified CpG sites ac-
cording to their hmC and mC frequencies. We first divided
all CpGs into three categories depending on the total modi-
fication (hmC+mC, or modC). In agreement with previous
studies [26], we determined that 89.8% of the CpGs are
highly modified (modChigh, modC ≥ 50%), 6.9% are un-
modified (modCno, modC < 10%), and 3.3% (n = 1,423,006)
are modified at low levels (modClow, 10% ≤modC < 50%)
(Figure 2a). Next, we divided the modChigh into three sub-
groups: (1) hmChigh: hmC >mC; (2) hmClow: hmC<mC;
and (3) hmCno: no hmC. We determined that hmChigh
Figure 1 Base-resolution hydroxymethylome and methylome in the human brain. (a) The percentages of hmCs or modCs in the adult or
the fetal brain in the contexts of CG, CHH, and CHG. (b) Examples of the hmC, mC, and total modification (hmC +mC) profiles are shown for a
genomic region of 12 mb on chromosome 4 as a scatterplot (Upper panel) and for a 12 kb region surrounding the TSS of the TET2 gene as a bar
chart. The green box indicates the CpG island located in the TET2 promoter.
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all captured CpGs. The hmClow (n = 20,857,810) and
hmCno (n = 11,695,002) categories comprised 49% and
27.4%, respectively. Since further analysis revealed that
hmClow and hmCno have similar characters, they were
grouped into mChigh referring to highly-methylated cyto-
sines (Figure 2a).
Genomic distribution of hmC in the human brain
Next, we determined the genomic distribution of modClow,
hmChigh, and mChigh. In addition to the annotated genomic
features, we also analyzed enhancers mapped by a recently
published ChIP-Seq dataset in the human brain [27]. Two
types of enhancers were distinguished: active enhancers
that were simultaneously marked by distal H3K4me1 andH3K27ac, and poised enhancers that were solely marked
by distal H3K4me1 [28]. modClow is prominently enriched
at enhancers (Figure 2b), which is in accordance with pre-
vious bisulfite studies [26]. We found that hmChigh is also
highly enriched at enhancers. In contrast to more enrich-
ment of modClow at active enhancers, hmChigh is more
enriched at poised enhancers (Figure 2b). Furthermore,
hmChigh is abundant at introns and exons. Most hmChigh
(56.9%) occur at genic regions (Additional file 5c), and this
is distinct from hmC distribution in ESCs [17]. By contrast,
mChigh are not enriched at enhancers or genic regions. We
calculated the hmC and mC levels of these genomic ele-
ments (Figure 2c). We observed that poised enhancers
have the highest hmC level (32.6% on average), followed by
active enhancers (28.6%), introns (27.8%), exons (27.7%),
Figure 2 Features of hydroxymethylome in the human brain. (a) Classification of all CpGs in the adult brain according to their
hydroxymethylation and methylation frequencies. (b) Fold enrichment of the CpG categories on different genomic elements. hmChigh is enriched
in enhancers, exons and introns. (c) The absolute hmC and mC levels at different genomic elements in the adult brain. (d) Fold enrichment of
the Fetal > Adult hmCGs, which exhibited higher hmC levels in the fetal brain than in the adult brain, on different genomic elements.
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reverse order, with the intergenic regions (58.2%) being
highest, followed by exons (57.4%), introns (56.4%), and en-
hancers (42.1% and 37.6% for poised and active enhancers,
respectively). The promoter regions have both the lowest
hmC and mC levels. Repetitive sequences, including LINE,
SINE, LTR, and major satellite repeats, generally have
lower hmC and higher mC levels than the non-repetitive
regions, and the major satellite repeats have the lowest
hmC level (5.4%).
We determined that the hmC levels of the fetal brain
are much lower than those of the adult brain in all gen-
omic regions (Additional file 5d). Despite this, we identi-
fied 102,569 CpGs that exhibited higher hmC levels in the
fetal brain than in the adult brain (both coverage ≥10,
methylation difference ≥0.3). Analysis for the genomic dis-
tribution of these Fetal > Adult hmCGs showed that they
are highly enriched at enhancers, but not at other genomic
features (Figure 2d). The result suggested that hmC
changes at enhancers are bidirectional with a subset of en-
hancers gaining and some losing hydroxymethylationfrom the fetal to the adult stage, which is consistent with
the previous report that hmC marks regulatory elements
in the fetal brain that is poised for subsequent activation
in the adult brain [25].
Prominent hmC peaks mark the exon-intron boundary
Despite previous suggestions that hmC may be associ-
ated with the exon-intron boundary in the brain [14],
the low-resolution method employed previously pre-
vented accurate analysis at the base resolution. Con-
versely, whole-genome BS-Seq studies have shown that
DNA modification is abundant on exons [29-31]. These
studies, however, were not able to distinguish between
mC and hmC. One intriguing finding of our analyses of
the base-resolution hmC and mC maps is two striking
hmC peaks at the 5′ splicing sites (5′ss), which are posi-
tioned flanking the highly conserved ‘GT’ sequence, with a
higher peak siting at positions -1 and -2 on the exon side
and a lower one at positions +4 and +5 on the intron side
(all internal exons, n = 176,455) (Figure 3a and Additional
file 6). In contrast, mC is not enriched. Notably, analysis
Figure 3 (See legend on next page.)
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Figure 3 Prominent hmC changes mark the exon-intron boundary. (a, b) Profiles of hmC and mC for a 40-bp window around the exon-intron
and intron-exon boundaries at single-nucleotide resolution in human (a) and mouse (b). Modification levels of hmC, mC, total DNA methylation (hmC+hmC),
and the CpG number are shown for all internal exons in the sense strand. The sequences ± 9 bp around the 5′ and 3′ splicing sites are also indicated. The
TAB-Seq and BS-Seq data to generate the mouse profile (b) were obtained from Lister et al. [25]. (c) Profiles of hmC and mC at the exon-intron boundary of
exons which have a CpG at 5′ss position -2 (-2CG, n=8,212) or -1 (-1CG, n= 4,277). Since a CpG at one position will lead to absence of CpG at the nearest
neighboring position and thus no methylation value, we merged the data of the sense and the antisense strands for each type of exons. (d) Profiles of hmC
and mC across exons. All internal exons were divided into 100 bins, and average hmC and mC levels were calculated for each bin, as well as ±150 bp
surrounding the exon. (e) The hmC and mC profiles at the exon-intron boundary of the first exon.
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BS-Seq (GSM1173783) data generated from the adult
mouse brain tissue (frontal cortex from 6-week-old male
mouse brain) [25] revealed two nearly identical hmC
peaks at the 5′ss, indicating that this pattern is conserved
in mammals (Figure 3b). The CpGs at both peaks are not
part of the consensus 5′ss sequence (CAG/GTAAGT).
However, the peak positions -2 and +4 have higher ten-
dencies to be CpG sites than the overall exons and introns
(Figure 3a and b). The profile of CpG distribution has
been recently reported [32]. We further determined that,
of the 176,455 examined human exons, 12,934 (7.3%, 4722
at position -1 and 8,212 at position -2) have CpG sites at
positions related to the exon-side peak and 5,514 (3.1%,
4605 at position +4 and 909 at position +5) have CpG sites
related to the intron-side peak (Figure 3a). Overall, these
exons (n = 18,036, 10.2% of all 176,455 human internal
exons) represent a large proportion of human genes (n =
9,103, 48.9% of all 18,606 human genes, see Additional file
7 for 5′ss sequences of these exons and the corresponding
genes). To exclude the possibility that the hmC peaks are
artifacts due to higher hmC levels of the exons which have
a CpG site at the 5′ss than those do not have, we separ-
ately analyzed the exons which have a CpG site at the 5′ss
position -2, -1, +4 or +5, and the results are similar to that
for all internal exons (Figure 3c and Additional file 8).
These results together indicated that prominent hmC
peaks mark the 5′ss at the exon-intron boundary in both
human and mouse, and are associated with a large cohort
of internal exons.
A decrease in hmC at positions +6 and +7 directly fol-
lowing the intron-side hmC peak was also observed for all
internal exons (Figure 3a and Additional file 5: Figure S4),
which seems to be similar to the intronic hmC decrease
reported previously [14]. In addition to these hmC
changes at the 5′ss, we also observed a marked increase in
mC and a less pronounced decrease in hmC from 5′ to 3′
across the exons (Figure 3c). We also examined the first
exons (n = 12,980), and found that they have higher CpG
occurrence and much lower hmC and mC levels than the
internal exons (Figure 3d), which should be due to their
proximity to promoter CpG islands. Interestingly, in con-
trast to the internal exons, mC is strongly enriched, and
hmC change follows the mC change. The distinctionbetween the internal exons and the first exons is suggest-
ive of a functional connection between the hmC peaks
and alternative exon inclusion, which should only occur in
the internal exons.
To determine whether the observed hmC and mC
changes are associated with gene expression, we generated
RNA-Seq data using RNA extracted from the same adult
brain sample for TAB-Seq and BS-Seq and divided the
expressed genes (RPKM >0.1) into three groups of identical
size of high, middle and low expression levels (Additional
file 9). The genes within these three groups, as well as
genes not expressed, displayed similar hmC changes
around their exon-intron boundary. This was unlike overall
hmC levels within both exons and introns, which positively
correlates to gene expression levels (Figure 4a). In addition,
the hmC decrease and the mC increase across the exon are
also similar among genes transcribed at different levels
(Figure 4b). These results suggested that the hmC and mC
changes occur irrespective of the transcription levels of the
corresponding genes.
Next, we address the potential functional relationship
between the DNA modification at the exon-intron bound-
ary and the splicing. We classified the exons having a CpG
site at the 5′ss position -2, -1, +4 or +5 into four types ac-
cording to the DNA modification states of the CpG site
(that is, mChigh, hmChigh, modClow, or modCno) and com-
pared their inclusion rates (see Materials and methods).
We also examined the number of the alternatively spliced
(AS) exon, which was defined as the inclusion rate being
less than 0.8. The results demonstrated that the hmChigh
and mChigh exons comprised a similar fraction of AS
exons (6.04% (128 out of 2,119 exons) vs. 5.63% (367 out
of 6,522 exons), Figure 4c), with the inclusion rates being
no difference (median 0.9901 vs. 0.9908, P = 0.13, two-
tailed Mann-Whitney-Wilcoxon (MWW) test, Figure 4d).
Also no difference was found comparing the hmChigh and
mChigh exons with the internal exons put together (me-
dian inclusion rate 0.9912, P >0.1, AS exons percent:
6.76% (6,929 out of 102,474 exons)). These results sug-
gested that hmC and mC at the 5′ss CpG site are similarly
related to splicing. Interestingly, the modClow and modCno
groups involved markedly more AS exons (9.67% (59 out
of 610 exons) and 18.76% (103 out of 549 exons), respect-
ively, Figure 4c). In addition, the inclusion rates of the
Figure 4 Correlation of the hmC and mC changes at the exon-intron boundary with gene expression and splicing. (a, b) The hmC
changes at the exon-intron boundary (a) and across the exon (b) are similar for exons expressed at high (red), middle (green), or low (blue) levels,
as well as exons with no expression (black). (c, d) The percentages of alternatively spliced exons (c) and the inclusion rates (d) of the exons with
the status of the 5′ss CpG site being mChigh, hmChigh, modClow, or modCno showing differential splicing of these exon types. Two-tailed MWW
test. n, number of exons.
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reduced comparing with the hmChigh and mChigh groups
(modClow vs. hmChigh: median 0.9885 vs. 0.9901, P = 0.04;
modCno vs. the hmChigh: median 0.9859 vs. 0.9901, P =
2.45 × 10-8, two-tailed MWW test, Figure 4d). These data
suggested that complete demethylation of mC and hmC
to C might lead to exon skipping, which is in line with
previous studies that DNA methylation facilitates exon
recognition [32,33].
Strand-biased hmC and mC on the gene body
Previous studies have reported that hmC is enriched on
gene bodies and positively correlated with gene expres-
sion in the adult brain [8,9,13,21,25]. We plotted the
average hmC and mC levels across the genes at high,
middle, and low expression levels and the data quantita-
tively confirmed that hmC is markedly enriched on the
gene body and positively correlated with gene expression
levels in the human adult brain (Figure 5a, left panel). Inaddition, we also showed that mC levels are clearly nega-
tively correlated with gene expression (Figure 5a, right
panel). Surprisingly, we observed that the hmC and mC
abundances are slightly but significantly different be-
tween the sense and antisense strands, with enrichment
of hmC on the sense strand and enrichment of mC on
the antisense strand. The differences are positively corre-
lated with gene expression levels as highly expressed
genes show the strongest biases, whereas genes that are
not expressed exhibit nearly no difference (Figure 5a).
To evaluate this pattern quantitatively and at a higher
level of resolution, all of the expressed genes were di-
vided into 10 equal-sized groups (approximately 1,400
genes for each group) based on their expression levels
and the gene-body mC and hmC levels were calculated
for each strand of the genes. The results revealed that,
from the lowest to highest expressed genes, an average
seven-fold increase in the hmC bias (%hmC of the sense
strand minus that of the antisense strand, from 0.09% to
Figure 5 (See legend on next page.)
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Figure 5 Strand-biased hmC and mC profiles on the gene body. (a) Profiles of hmC (left panel) and mC (right panel) on the sense (lined)
and antisense (dotted) strands of the genes expressed at high (red), middle (green) and low (blue) expression levels, as well as the genes with no
expression (black). TSS and TTS indicate the transcription starting site and the transcription terminal site, respectively. (b) Expressed genes were
divided into 10 groups according to the expression levels (left panel), and the average levels of hmC (middle panel) and mC (right panel) for
each strand of the gene body were measured. The values for the genes that are not expressed (expression level 0) and randomly selected
intergenic regions as the control (C) are also shown. One-tailed paired Student’s t test. nd, no statistical difference (P >0.05). (c) Profiles of hmC
on the sense (lined) and antisense (dotted) strands of exons with high (red) or no (black) expression. (d) The hmC and mC strand-biases are
reduced at the sense-antisense gene (SAS) paired regions in comparison with the non-SAS regions. (e) The hmC profile on the sense (lined) and
antisense (dotted) strands of the genes that are expressed (red) or not expressed (black) in the mouse brain exhibits the transcription-correlated hmC
bias toward the sense strand similar to the human pattern. The TAB-Seq, BS-Seq, and RNA-Seq data for analysis were obtained from Lister et al. [25].
Wen et al. Genome Biology 2014, 15:R49 Page 9 of 17
http://genomebiology.com/2014/15/3/R490.69%) and an average five-fold increase in the mC bias
(%mC of the antisense strand minus that of the sense
strand, from 0.22% to 1.04%) were observed (Figure 5b).
Also, the strand differences of both hmC and mC are
significant (for example, P = 1.63 × 10-23 for hmC and
P = 4.4 × 10-13 for mC in genes of express group 9, two-
tailed and paired Student’s t-Test, see Additional file 10
for all calculated P values, as well as the hmC, mC, and
modC levels on each strand of all individual genes). Both
hmC and mC also displayed a slight difference in genes
that are classified as not expressed (n = 8,789), but these
differences were not statistically significant (P = 0.39 for
hmC and P = 0.44 for mC). No strand difference was
found for randomly-selected intergenic regions (Figure 5b).
Also, for most expression levels, the strand differences of
the total modification were not significant as measured by
BS-Seq (Additional file 11), explaining why it has not been
observed in previous studies using BS-Seq alone.
Then we plotted the average hmC and mC levels
across each strand of the exon and the results showed
that the exon exhibited the strand difference at a similar
level as that of the gene body, suggesting that the DNA
methylation strand difference is a general feature of the
transcribed exons and introns (Figure 5c and Additional
file 12). To further verify the strand-bias, we analyzed
the sense-antisense (SAS) gene paired regions. Since
within these regions, each strand serves as both sense
and antisense strands, it is expected that the strand dif-
ference should be lessened. The results indeed showed
that both the hmC and mC biases decreased in the SAS
regions, with a 39% reduction in the hmC bias (0.45% in
non-SAS region vs. 0.28% in SAS region) and a 66% re-
duction in the mC bias (0.89% in non-SAS region vs.
0.3% in SAS region, Figure 5d). To generalize our obser-
vation, we analyzed the recently published TAB-Seq and
BS-Seq data in the adult mouse brain [25]. The results
notably showed that the mouse brain cells share a simi-
lar transcription-associated hmC bias toward the sense
strand (Figure 5e) and an mC bias toward the antisense
strand (Additional file 13), indicating that these hmC
and mC features are evolutionary conserved between
mouse and human.To determine whether the hmC and mC strand biases
are cell type-specific, we examined genes enriched in
different brain cell types including neurons (n = 1,417),
astrocytes (n = 1,807) and oligodendrocytes (n = 1,453)
[34]. We found that all three gene sets and the house-
keeping genes (n = 2,402) [35] exhibited enrichment
of hmC on the sense strand and enrichment of mC on
the antisense strand (P <0.001, Figure 6a). Furthermore,
to independently validate our findings, we isolated
neuronal nuclei by FACS (Figure 6b and Additional file
14) and employed a Tet-assisted reduced representation
bisulfite sequencing (TA-RRBS) approach by perform-
ing TAB-Seq on MspI-enriched DNA fragments of
genomic DNAs extracted from these neuronal nuclei,
and then quantified the hmC levels on both stands of
the neuron-enriched genes. The results confirmed that
hmC is significantly enriched on the sense strands of
the neuronal genes at high expression levels (for ex-
ample, P = 2.4 × 10-7 for expression level 4, Figure 6b).
The strand difference is not significant for genes
expressed at low levels (P >0.05 for expression levels 1
and 2, Figure 6b). Together, our data indicated a
transcription-correlated hmC bias toward the sense
strand and an mC bias toward the antisense strand of
the gene body in both neurons and glia in the human
and mouse adult brain.
hmC is enriched at poised enhancers and is negatively
correlated with repressive histone modifications
Next, we associated the hmC/mC profiles with the
ChIP-seq data of various chromatin modification marks
[27]. At the active enhancer, both hmC and mC levels
are depleted towards the core region, and hmC is rela-
tively accumulated at the flanking region. At the poised
enhancer, both modifications revealed less pronounced
reduction at the core region, particularly for hmC
(Figure 7a). The difference in hmC profiles between the
active and poised enhancers is more strikingly displayed
by the high proportion of the hmChigh subgroup at the
core region of the poised enhancer (Additional file 15).
These results are consistent with previous reports in ESCs
[15,17] and in the mouse brain [25], suggesting that hmC
Figure 6 Strand-biased hmC and mC profiles in both neurons and glia. (a) The average levels of hmC (left panel) and mC (right panel) for
each strand of genes enriched in different brain cell types including neurons, astrocytes and oligodendrocytes (OLs), as well as the house-keeping
genes (HKGs). (b) Tet-assisted reduced representation bisulfite sequencing performed in neuron nuclei isolated by FACS using the NeuN antibody
(left panel) revealed that hmC is significantly enriched on the sense strands of the neuronal genes expressed at high (3, 4, 5), but not low (1, 2)
expression levels (right panel). One-tailed paired Student’s t test. nd, no statistical difference (P >0.05).
Figure 7 hmC/mC profiles on enhancers and repressive genomic regions. (a) The hmC, mC, and total DNA methylation levels, and the
hmC/mC ratios were displayed surrounding the midpoints of active or poised enhancers, or across H3K27me3- and H3K9me3-enriched regions.
Arrows indicate the starting and ending points of the H3K27me3- and H3K9me3-marked regions. (b) An example of a 600-kb genomic region
surrounding the APP gene showing enrichment of hmC and H3K4me1 within the genic region and enrichment of mC and H3K27me3 in the
neighboring intergenic regions. ChIP-Seq data for H3K4me1, H3K4me3, and H3K27me3 were obtained from Zhu et al. [26].
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ture of enhancers in the human adult brain.
Lastly, we address the relationship between DNA modifi-
cation and two repressive histone modifications, H3K27me3
and H3K9me3. The results demonstrated that hmC is
clearly depleted at these repressive regions, with the average
hmC levels of both the H3K27me3 and H3K9me3 regions
being lower than the overall intergenic regions (20.5% vs.
23.9% and 14.6% vs. 23.9%, respectively, Figure 7a). By con-
trast, the mC levels in both of these repressive regions are
higher than at the overall intergenic regions (approximately
64.4% vs. 58.2%, Figure 7a). An example of depletion of
hmC on the genomic regions marked by H3K27me3 and
H3K9me3 was provided in Additional file 16. It was shown
recently that brain tissues exist in a unique chromatin state,
with expansion of H3K27me3 over a particularly large
proportion of the intergenic regions, accompanied by a dra-
matic restriction of H3K4me1 sites within the transcrip-
tional units [27]. The association of our hmC/mC profiles
with these two histone modification maps, as well as
H3K4me3 peaks at the promoter regions, can be viewed in
genomic regions surrounding the amyloid precursor protein
(APP) and Neurexin 1 (NRXN1) gene loci as examples
(Figure 7b and Additional file 17), which are representative
of transcribed genes in the adult brain.
Conclusion
In this study, we mapped DNA hydroxymethylation and
methylation across the whole genome at single-base
resolution in the human brain by combined application
of TAB-Seq and BS-Seq, which revealed several novel in-
sights regarding the nature of DNA methylation in brain
tissues. The first intriguing finding of this study is the
two striking hmC peaks at the 5′ss, that is, the sharp in-
crease in hmC levels at positions -1 and -2 at the exon
side and at positions +4 and +5 at the intron side sur-
rounding the highly conserved ‘GT’ splicing sequence. A
previous study has revealed enrichment of DNA modifi-
cation (hmC +mC) at the exon-intron boundary in
human embryonic stem cells and fibroblast [30]. Since
BS-Seq alone was applied in this study, mC and hmC were
not distinguished. In the present study, by the combined
use of TAB-Seq and BS-Seq, we unexpectedly found that
it is the hmC that forms peaks at the 5′ss in the adult
human brain whereas mC is not enriched. This finding
suggested that hmC is the key modification marking the
exon-intron boundary in the adult brain tissues. It de-
serves to be mentioned that this pattern is evolutionary
conserved since the mouse brain cells share similar hmC
and mC features at the exon-intron boundary. A recent
study also revealed significant hmC but not mC changes
at the exon-intron boundary in the human and mouse
brain. However, using an enzymatic method which rec-
ognized hmCs in the context of ChmCGG, this studyonly detected the intronic hmC decrease, while the more
significantly marked hmC peaks were not reported [14].
Further studies are needed to elucidate how hmC peaks at
the 5′ splicing sites are mechanically linked to spli-
cing, which is under regulation by chromatin structures
[36]. The results may indicate a high turnover rate of
DNA methylation at the 5′ss, or that the hmC specific-
ally recruits reader proteins that directly or indirectly
affect splicing. Interestingly, our analysis suggested that
both hmC and mC may facilitate exon recognition. This
may be related with the reports that MeCP2 (methyl-
CpG-binding protein 2), an extremely abundant protein in
brain, binds to hmC and mC with similar high affin-
ities and helps exon recognition [21,33].
Second, our data revealed a surprising transcription-
correlated hmC bias toward the sense strand and an mC
bias toward the antisense strand of the gene body in the
adult brain tissues of both human and mouse. In con-
trast to the well-established role of DNA methylation in
CpG island promoter regions for transcription repres-
sion, the function of gene body methylation is still
largely unknown [37-41]. Previous studies have revealed
a positive correlation between gene expression and the
gene-body mC level [39-42]. More recently, we and
others have shown the gene-body hmC level is also posi-
tively correlated with gene expression in brain tissues
and germ line cells [8,9,16,21,25]. While it has been hy-
pothesized that the function of gene-body methylation is
to repress spurious initiation of transcription within ac-
tive genes including that from the repetitive elements
[41,43], our finding implies to an intrinsic link between
the transcription elongation and the DNA modification
processes. Interestingly, an enrichment of non-CG methy-
lation on the antisense strand has been observed in ESCs
previously [29]. Regarding the establishment of this strand
bias, one possibility is that the antisense strand acts as the
template for mRNA transcription; the non-template
strand might thus be more accessible to TET proteins in
some way, resulting in the enrichment of hmCG and,
hence, the accumulation of mCG and non-CG methyla-
tion on the template strand. The asymmetry distribution
of DNA hydromethylation and methylation might also be
interpreted in brain cells to play some regulatory roles in
transcription, which should need further functional studies
in the future.
Third, we demonstrated that, in the adult human
brain, 13.4% of all CpGs (n = 5,692,354) are highly-
hydroxymethylated (the hmChigh category). Since hydro-
xymethylation is the main modification status of these
CpG sites, it points to a regulatory role of these CpG sites
when hydroxymethylated. Indeed, we found that this CpG
category is strongly enriched at enhancers and genic re-
gions, which is distinct from the highly-methylated
(mChigh), as well as the lowly-hydroxymethylated (hmClow,
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enriched at poised enhancers, which is distinct from en-
richment of modClow at active enhancers. Finally, we
showed that the hmC level is greatly reduced in
H3K27me3-marked regions, which is different from its en-
richment on the H3K27me3-associated bivalent promoters
in ESCs [5-7]. This difference should be associated with the
dramatic expansion of H3K27me3 in differentiated cells
and tissues including the brain [27]. It will be of interest to
investigate how these highly-hydroxymethylated CpG sites
might contribute to the regulation of the unique chromatin
organization in the brain tissues.
In summary, we present the genome-wide and single-
base-resolution maps of hmC and mC in the human
brain. The results imply novel roles for hmC in gene
splicing and gene expression regulation. The identified
highly-hydroxymethylated CpGs, which comprise 13.4%
of all CpGs in human genome and are strongly enriched
at poised enhancers and actively transcribed regions,
also serve as a starting point for future investigations on
the mechanisms that establish hydroxymethylation pat-
terns and their associated functions in the human brain.
Materials and methods
Biological samples and genomic DNA extraction
This project was approved by the Reproductive Ethics Com-
mittee of Peking University Third Hospital (2012SZ010).
Brain tissues for research were obtained with the written
informed consent. The methods applied in this study are
complied with the Helsinki Declaration. For TAB-Seq and
BS-Seq, the adult human brain samples were obtained from
a postmortem 42-year-old woman, and the fetal brain sam-
ples were obtained from an aborted 22-week-old male fetus.
For LC-MS/MS, another adult human brain sample was ob-
tained from a postmortem 28-year-old man, and another
fetal sample was obtained from an aborted 22-week-old fe-
male fetus. All individuals had no sign of brain disea-
ses. Genomic DNAs were extracted using Blood & Cell
Culture DNA Kits (Qiagen) following the manufacturer’s
instructions.
Preparation of genomic DNA for TAB-Seq
For TAB-Seq, genomic DNAs and spike-in control
DNAs were sheared to an average size of 200 bp using a
Covaris S2 instrument. Glycosylation and oxidation of
genomic DNAs was performed following a previous
protocol with small modifications [44]. Briefly, 5 μg of
sheared genomic DNA or with spike-in controls was ini-
tially glycosylated using β-glucosyltransferase proteins
that were expressed and purified as previously described.
Then, the DNA was purified using the QIAquick Nu-
cleotide Removal Kit (Qiagen). Next, the oxidation reac-
tion was performed using 1.5 μg of glycosylated DNA
and 30 μL recombinant mTet1 protein in a 150 μLreaction solution and incubated for 1 h at 37°C. After
proteinase K treatment, the oxidized DNA was first
purified with Micro Bio-Spin 30 Columns (Bio-Rad) and
then with 1.8 × Ampure XP Beads (Beckman) following
the manufacturer’s suggestions.
For Tet-assisted reduced representation bisulfite se-
quencing (TA-RRBS), genomic DNAs extracted from
purified neuron nucleus were first digested with MspI for
3 h at 37°C and purified using the QIAquick Nucleotide
Removal Kit as described [45]. Then, glycosylation and
oxidation of the DNA was performed similar to the
TAB-Seq.
Library preparation for TAB-Seq, BS-Seq, and sequencing
The DNA sample for BS-Seq was the same batch of
sheared genomic DNA with spike-in controls that was
used for TAB-Seq but without glycosylation and oxidation
preparation. DNA samples for TAB-Seq and BS-Seq (0.5 to
1 μg) were end-repaired, A-tailed, and ligated to methyl-
ated adaptors using Illumina TruSeq Sample Preparation
Kits following the manufacturer’s instructions. The ligated
fragments were then bisulfite converted using the Methyl-
Code Kit (Invitrogen). Bisulfite-treated DNA was separated
into three reactions for PCR amplification using PfuTurbo
Cx Hotstart DNA polymerase (Agilent Technologies) for
seven cycles, yielding three independent libraries for the
same biological sample. Final libraries were purified with
1× AMPure XP beads and sequenced using an Illumina
Hiseq 2000. For Tet-assisted reduced representation bisul-
fite sequencing, an additional size selection of 180 to
600 bp fragments on a 2% agarose gel was performed after
the adapter ligation.
Spike-in controls for TAB-Seq, TARRBS, and BS-Seq
Fully methylated Lambda DNA was added to the human
brain genomic DNAs in a ratio of 1 to 200 as a spike-in
DNA control to calculate the non-conversion rates of
unmodified cytosine and mC. For the spike-in control to
calculate the non-conversion rates of hmC, a DNA frag-
ment of approximately 1.6 kb was amplified from a
pUC19 vector using a primer pair (5′-GCAGATTG
TACTGAGAGTGC-3′ and 5′-TGCTGATAAATCTG
GAGCCG-3′) and a cocktail of dATP/dGTP/dTTP and
dhmCTP (Zymo Research, Cat. No. D1045). The control
was then added to genomic DNA at a ratio of 1 to 400.
RNA preparation and sequencing
Total RNA was extracted from the tissue sample using
QIAGEN RNeasy Mini Kits (Qiagen), and mRNA was
isolated by Sera-Mag Oligo (dT) beads (Thermo Scien-
tific). Libraries were prepared using the NEB Next
mRNA Sample PreP Master Mix Set 1 according to the
manufacturer’s protocol and sequenced using an Illu-
mina Hiseq 2000.
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Genomic DNA (2 μg) was digested by nuclease P1, venom
phosphodiesterase I (Type VI), and alkaline phosphatase
(Sigma). After desalting and filtration, 10 μL of the solution
was injected into HPLC-MS/MS for analysis. HPLC-MS/
MS was carried out by reverse-phase ultra-performance li-
quid chromatography on an Agilent ZORBAX Eclipse
XDB-C18 column (Rapid Resolution HT, 50 × 2.1 mm P.N.
927700-902), equipped with a ZORBAX Eclipse XDB-C8
guard column (Column: P.N. 821125-926, Cartridges P.N.
820555–901), eluted with buffer A (0.1% formic acid in
H2O) and buffer B (0.1% formic acid in methanol) with a
flow rate of 0.5 mL min-1 at 35°C with a 2% to 25% gradi-
ent in 4.5 min, with online mass spectrometry detection
using Agilent 6410 triple-quadrupole (QQQ) LC mass
spectrometer in multiple reaction monitoring (MRM) posi-
tive electrospray ionization (ESI) mode. The nucleosides
were quantified using the nucleoside-to-base ion mass
transitions of 258 to 142 with collision energy of 1 eV
(hmC) and 228 to 112 with collision energy of 5 eV (C).
Quantification and detection limits were determined by
comparison with the standard curves obtained from nu-
cleoside standards running at the same volume and time.
Neuronal nuclei isolation
Nuclei extraction was processed as described [46].
Briefly, 500 mg of cryopreserved human left frontal cor-
tex was homogenized on ice by douncing in 5 mL lysis
buffer (0.32 M Sucrose, 5 mM CaCl2, 3 mM, 0.1 mM
EDTA, 10 mM Tris-HCl (pH 8.0), 1 mM DTT, and 0.1%
TritonX-100). Homogenates were transferred to ultra-
centrifuge tube, with Sucrose Solution (1.8 M Sucrose,
3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl
(pH 8.0)) carefully pipetted at the bottom of the tube to
form a concentration gradient. Ultracentrifugation was
performed at 100,000 g for 2.5 h at 4°C. After centrifuge,
supernatant including debris was removed and the pellet
was incubated in 0.5 mL cold PBS on ice for 20 min be-
fore thoroughly triturated by pipetting.
Immunostaining mix was prepared by combining
300 μL PBS, 1.2 μg NeuN antibody (Millipore, MAB377),
200 μL Blocking Mix ( 2.5% BSA and 10% Goat Serum in
PBS), and 2 μg of Alexa Fluor 488 conjugated secondary
antibody (Cell Signaling, #4488) together and rotated for
5 min at room temperature in the dark. An isotype anti-
body control was processed in parallel by adding the same
amount of mouse IgG instead of NeuN antibody. Then
1 mL nuclei suspension was added, and the mixture was
incubated by rotating in the cold room for 45 min. After
incubation, samples were retrieved and stained with
Hoechst 33342 for another 2 min. The immunostaining
result was checked under the microscope.
Immumotagged samples were diluted 10 times in PBS
and filtered through a 40 μm filter before loaded to theFACS machine. A preliminary run was performed to
gate out the proper nuclei size and the fluorescence
bright population before the sort which separate the
NeuN + nuclei. Once the sort was done, a small amount
of sorted sample was run again through the instrument
to confirm the purity.
After FACS, PBS was added to raise the volume of the
sort to 10 mL. Then the sorted sample was mixed with
2 mL Sucrose Solution, 50 μL CaCl2 (1 M), and 30 μL Mg
(Ac)2 (1 M), and incubated on ice for 15 min before cen-
trifuged at 1,786 g for 15 min at 4°C. The NeuN+ nuclei
pellet was resuspended in PBS and went on with the Tet-
assisted reduced representative bisulfite sequencing.
Data processing
FASTQ format reads generated by the Illumina HiSeq2000
platform were aligned to the human reference sequence
(HG19) using the Bismark program. Briefly, first, whole or
any subsets of adaptor sequences were trimmed on 3′ and
5′ of reads before alignment. Second, a read was removed
if more than 10% bases were N, or more than 50% bases
were of Phred quality lower than 5, or at least three
unmethylated CHs were present, or PCR redundancy oc-
curred, so that only high quality data were used for down-
stream analysis, as described previously [17,29]. Third,
cytosines in a read were computationally replaced with
thymines and then mapped to computationally converted
HG19 references using the Bismark program. The Lambda
genome and the pUC19 sequences for the hmC spike-in
control were also included in the reference sequence as
extra chromosomes for assessing the non-conversion rates
of unmodified cytosine, mC, and hmC.
Assessing the non-conversion rates of unmodified
cytosine, mC, and hmC and the protection rate of hmC
The non-conversion rate of unmodified cytosine was calcu-
lated as the percentage of sequenced cytosines in non-CG
contexts relative to all covered cytosines in non-CG con-
texts in the Lambda genome. The non-conversion rate of
mC was calculated as the value in a CG context, and the
non-conversion rate of hmC was measured as the value for
all cytosines in the spike-in pUC19 sequences. The original
data are shown in Additional file 1: Table S1. The normal-
ized protection rate of hmC was assessed by dividing the
non-conversion rate of hmC of TAB-Seq by that of BS-Seq.
Assessing the false discovery rates of modC and hmC
The P value for each cytosine detected by TAB-Seq and
BS-Seq was calculated via binomial distribution as previ-
ously described [17,29]. To measure a false discovery
rate (FDR) for the modC and hmC sites passing a given
P value cutoff, we applied the Benjamini-Hochberg
method [47] and set the FDR <0.01. The FDR was calcu-
lated separately for each chromosome and cytosine in
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plied the method described previously [17] to calculate
the FDR for the TAB-Seq data and found that although
this method yielded similar results for the fetal TAB-Seq
data and for cytosines in the CHG and CHH contexts in
the adult TAB-Seq data with a FDR <0.05, the FDR was
higher than 0.1 even at a P value of 1E-8 when applying
it to the adult TAB-Seq data. This is likely because the
number of bona fide hydroxymethylated cytosines of the
adult brain is much greater than those of ESCs and the
fetal brain. To be consistent, we applied the Benjamini-
Hochberg method for both the adult and fetal TAB-Seq
data. For calculating the FDR for the BS-Seq data, the
Benjamini-Hochberg method yielded a similar result
with the method described by Lister et al. [29].
Modification frequency of individual CpG sites
The modC frequency was calculated as dividing modCG
by the total coverage according to the BS-Seq data
(modCG/CG). The hmCG frequency was similarly calcu-
lated according to the TAB-Seq data (hmCG/CG), and
the mCG frequency was calculated by subtracting
hmCG/CG from modCG/CG.
Quantification of the hmC and mC levels
The hmC level (%hmC) at a given genomic region or site
is calculated by dividing the number of sequenced cyto-
sines by the number of sequenced cytosines plus thymines
at this region or site according to the TAB-Seq data, where
the reference is in CG context. The mC level (%mC) is cal-
culated by subtracting %hmC from the total modification
level (%(hmC +mC)) according to the BS-Seq data.
Genome annotation
All genomic features were defined based on the HG19
genomic annotation downloaded from the UCSC data-
base. Different genic elements, including transcription
start sites (TSS), exons, introns, and transcription ter-
minal sites (TTS), were defined based on the Reference
Sequence (RefSeq) database. The CGIs were retrieved
from the cpgIslandExt table in UCSC database, and pro-
moter CGIs were defined as overlapping with ± 1 kb of
TSS. Repetitive sequences (SINE, LINE, LTR, and Major
Satellite) were acquired from the Repeat-Masker track in
the UCSC database.
Calculating enrichment of CpG categories on genomic
elements
For a given CpG group (modClow, mChigh, hmChigh, or
Fetal > Adult hmCGs), we counted the fraction of the in-
volved CpG sites at each genomic element as the ‘ob-
served’ distribution value. We also counted the fraction
of the overall captured genomic CpG sites at each gen-
omic element as the ‘expected’ distribution value. Thefold enrichment value for each genomic element was
calculated by dividing the ‘observed’ distribution value
by the ‘expected’ distribution value.
Profiling hmC and mC at the exon-intron boundaries
A total of 176,455 internal exons representing 18,606
genes were retrieved from the RefSeq database, with ex-
clusion of all first last exons and single-exon genes. A total
of 12,980 first exons were also retrieved. The average
hmC, mC, and modC levels, the hmC/mC ratio, the num-
ber of four modCG groups relative to all CpGs, and the
CpG sites were calculated for each base ± 150 bp around
the exon-intron boundaries. The base composition was
also measured ± 10 bp around the 5′ and 3′ splicing sites.
Calculation of exon inclusion rates
To identify exons that are alternatively spliced, we followed
the method described previously [14] with modifications.
First, a library of exon-exon junction (EEJ) sequences that
comprised all possible exon-exon combination for a gene
was generated. Second, RNA-Seq data generated in this
study were merged with RNA-Seq data of human cerebral
cortex generated previously [48], and then were aligned to
the EEJ library using the Bowtie program. Reads mapping to
the genomic sequences were discarded before alignment. To
determine an EEJ, at least eight mapped nucleotides were
needed for each of the two exons. Then, the generated EEJ
data were used for calculation of the inclusion value of an
exon as ‘% inclusion = 100 × (sum(CiA) + sum(ACj))/((sum
(CiA) + sum(ACj) +2 × (sum(CiC2) + sum(C1Cj)))’, where
Ci is any possible splicing donor upstream the alternative
exon, C1 is the first splicing donor upstream the alternative
exon, Cj is any possible splicing acceptor downstream the al-
ternative exon, C2 is the first splicing acceptor downstream
the alternative exon, and A indicates the examined exon. A
minimum of 10 supporting reads are required and exons
without a AG dinucleotides at the 3′splicing sites are omit-
ted. An alternatively spliced exon was defined when the in-
clusion value was less than 0.8.
Strand-biased hmCG and mCG profiles on gene bodies
Gene body regions between TSS and TTS were divided
into 100 equally sized bins, and average hmC and mC levels
were calculated for each bin as well as in 100-bp windows
throughout 10 kb upstream and downstream of the gene
body. The sense strand and the antisense strand were ex-
amined separately. A two-tailed and paired Student’s t-Test
was applied to determine whether the sense and antisense
strand were significantly different from each other.
Identification of the sense-antisense (SAS) gene paired
region
All expressed genes (RPKM ≥1) were divided into two
groups according to whether they are transcribed along
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paired region was identified as the overlap region be-
tween these two gene groups.Identification of cell type-specific genes and
house-keeping genes
Genes enriched in different brain cell types including
neurons, astrocytes, and oligodendrocytes were defined
according to a previous paper with exclusion of genes
that are not expressed in our RNA-Seq data [34]. The
house-keeping genes were defined according a previous
publication [35].Association of hmC and mC profiles with ChIP-Seq data
To profile the distribution of hmC and mC on genomic re-
gions with different histone modifications, we used the re-
cently published genome-wide maps of chromatin states in
the adult brain midfrontal lobe [27], including H3K4me1,
H3K27ac, H3K4me3, H3K27me3, and H3K9me3.
Enhancers were defined as H3K4me1 peaks that are dis-
tant from ± 2.5 kb around any TSS in the switchDbTss
table downloaded from the UCSC database. To produce
the profiles in Figure 4A, we selected enhancers within in-
tragenic regions, which account for approximately two-
thirds of enhancers in the adult human brain [9]. For CGI
shores, we selected promoter CGIs. We checked a region
± 5 kb around the center of the H3K4me1 peak and 3 kb
upstream and downstream of CGIs. For all profiling, the
average hmC, mC, and modC levels, the hmC/mC ratio,
and the number of the four modCG groups (hmChigh,
mChigh, mCall, and modClow) relative to all CpGs were
binned into 50-bp sliding windows in 25-bp steps.
To profile hmC and mC in H3K27me3- and
H3K9me3-marked regions, each region was divided into
100 equally sized bins, and average hmC, mC, and
modC levels and the hmC/mC ratio were calculated for
each bin, as well as in 1-kb windows throughout 10 kb
upstream and downstream of the regions.Accession numbers
The TAB-Seq and BS-Seq data have been deposited to
the NCBI under accession number GSE46710, and the
TA-RRBS data have been deposited under accession
number GSE55249.Additional files
Additional file 1: Table S1. Summary of sequencing details.
Additional file 2: Figure S1. Quantitative values of hmC relative to dC
measured by LC-MS/MS. LC-MS/MS was performed to genomic DNAs
isolated from several regions of two adult brain and two fetal brain
samples. For each sample, the average value with the standard deviation
from technical duplicates was shown.Additional file 3: Figure S2. Chromatograms of LC-MS/MS. The LC-MS/
MS chromatograms of hmC (left panels) and C (right panels) for genomic
DNAs extracted from the adult (a) and fetal (b) frontal lobes were shown
with the standard curve (c). The peak area counts are marked. Please go
to the figshare website [49] for all the raw chromatograms.
Additional file 4: Figure S3. The percentages of hmC (by TAB-Seq) or
modC (by BS-Seq) in the fetal hippocampus in the contexts of CG, CHH,
and CHG.
Additional file 5: Figure S4. Features of hydroxymethylome in the
human brain. (a, b) Distribution of all covered CpGs according to their
hydroxymethylation and methylation frequencies in the adult (a) and the
fetal (b) brains. (c) Distribution of the CpG categories (modClow, mChigh,
and hmChigh) and all captured CpGs (All CpGs) on different genomic
elements. (d) Average absolute levels of hmC at different genomic
elements in the fetal brain.
Additional file 6: Figure S5. Prominent hmC changes at the exon-intron
boundaries in the human brain. Profiles of hmC and mC for a 200-bp
window (50 bp for exon and 150 bp for intron) around the exon-intron and
intron-exon boundaries. Modification levels of hmC, mC, total DNA methylation
(hmC+ hmC), and the ratio of hmC to mC are shown for all internal exons
(n= 176,455) in the sense strand.
Additional file 7: Table S2. Information of 18,036 exons having CpG
sites at 5′ splicing sites.
Additional file 8: Figure S6. Profiles of hmC and mC at the exon-intron
boundary of exons which have a CpG at 5'ss position +4 or +5. Modification
levels of hmC, mC, total DNA methylation (hmC + hmC) were shown for a
40-bp window around the exon-intron boundaries at single-nucleotide
resolution of two types of exons, which have a CpG at 5′ss position +4
or +5, and are named +4CG and +5CG exons, respectively. Since a CpG at
one position will lead to absence of CpG at the nearest neighboring
position and thus no methylation value, we merged the data of the sense
and the antisense strands for each type of exons.
Additional file 9: Table S3. All expressed genes in the adult human
brain revealed by RNA-Seq.
Additional file 10: Table S4. hmC, mC, and modC levels on each
strand of all individual genes.
Additional file 11: Figure S7. The average levels of modC on sense and
antisense strands of genes expressed at different levels in the adult brain.
One-tailed paired Student’s t test. nd, no statistical difference (P >0.01).
Additional file 12: Figure S8. The mC profiles across each strand of
the exon. The profile across exons of sense (lined) and antisense (dotted)
strands of highly-expressed genes (red) and no-expression genes (black)
in the adult brain showed that a transcription-correlated mC bias toward
the antisense strand of the exon.
Additional file 13: Figure S9. The mC profiles across each strand of
the gene body in the mouse brain. The profile across genes of the sense
(lined) and antisense (dotted) strands of expressed genes (n = 11,424, red)
and genes with no expression (n = 5,203, black) in the adult mouse brain
showed that a transcription-correlated mC bias toward the antisense
strand of the gene body in the mouse brain. The TAB-Seq, BS-Seq, and
RNA-Seq data for analysis were obtained from Lister et al. [25].
Additional file 14: Figure S10. FACS scatter plot for the control
sample for isolation of neuronal nuclei, which was processed with IgG.
Additional file 15: Figure S11. Distribution of modClow, mChigh, and
hmChigh surrounding the midpoints of active or poised enhancers.
Additional file 16: Figure S12. hmC and mC maps in a 2-mb genomic
region on chromosome 11. This example shows depletion of hmC and
enrichment of mC on the H3K9me3- and H3K27me3-marked repressive
regions. ChIP-Seq data for H3K4me1, H3K4me3, H3K9me3, and
H3K27me3 were obtained from Zhu et al. [26].
Additional file 17: Figure S13. hmC and mC maps in a 2.8-mb
genomic region surrounding the NRXN1 gene. This example shows
enrichment of hmC and H3K4me1 within the genic region and
enrichment of mC and H3K27me3 in the neighboring intergenic regions.
ChIP-Seq data for H3K4me1, H3K4me3, H3K9me3, and H3K27me3 were
obtained from Zhu et al. [26].
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